EA201390979A1 - Композиции бензимидазолов с модифицированным высвобождением - Google Patents

Композиции бензимидазолов с модифицированным высвобождением

Info

Publication number
EA201390979A1
EA201390979A1 EA201390979A EA201390979A EA201390979A1 EA 201390979 A1 EA201390979 A1 EA 201390979A1 EA 201390979 A EA201390979 A EA 201390979A EA 201390979 A EA201390979 A EA 201390979A EA 201390979 A1 EA201390979 A1 EA 201390979A1
Authority
EA
Eurasian Patent Office
Prior art keywords
benzimidazoles
compositions
survival
modified
modified survival
Prior art date
Application number
EA201390979A
Other languages
English (en)
Inventor
Лингам Мека
Сриниваса Алмаредди Редди
Вагиша Синха
Хитеш Джоджия
Сринивас Арутла
Равирадж Пиллаи
Рахул Судхакар Гаванде
Прасад Вуре
Венкатесварлу Вобалабоина
Original Assignee
Др. Редди'С Лабораторис Лтд.
Др. Редди'С Лабораторис, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Др. Редди'С Лабораторис Лтд., Др. Редди'С Лабораторис, Инк. filed Critical Др. Редди'С Лабораторис Лтд.
Publication of EA201390979A1 publication Critical patent/EA201390979A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Фармацевтическая композиция, обеспечивающая более чем одно высвобождение бензимидазольного лекарственного средства. В некоторых вариантах воплощения изобретения, содержащие лекарственное средство частицы покрывают, по меньшей мере, одним полимером, имеющим растворимость при значениях рН от около 5 до около 7,5, и другие содержащие лекарственное средство частицы покрывают, по меньшей мере, одним полимером, имеющим растворимость при значениях рН от около 5 до около 6.
EA201390979A 2010-12-29 2011-12-29 Композиции бензимидазолов с модифицированным высвобождением EA201390979A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN4013CH2010 2010-12-29
US201161447759P 2011-03-01 2011-03-01
PCT/US2011/067868 WO2012092486A2 (en) 2010-12-29 2011-12-29 Modified release benzimidazole formulations

Publications (1)

Publication Number Publication Date
EA201390979A1 true EA201390979A1 (ru) 2013-12-30

Family

ID=46383862

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201390979A EA201390979A1 (ru) 2010-12-29 2011-12-29 Композиции бензимидазолов с модифицированным высвобождением

Country Status (7)

Country Link
EP (1) EP2661260A4 (ru)
CN (1) CN103402501A (ru)
AU (1) AU2011352037A1 (ru)
EA (1) EA201390979A1 (ru)
NZ (1) NZ613090A (ru)
UA (1) UA112855C2 (ru)
WO (1) WO2012092486A2 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013064535A1 (en) * 2011-11-02 2013-05-10 Laboratorios Del Dr. Esteve, S.A. Pharmaceutical composition of omeprazole
MX2015010041A (es) 2013-02-05 2015-10-30 Purdue Pharma Lp Formulacion farmaceuticas resistentes a la alteracion.
US9539265B2 (en) 2013-03-15 2017-01-10 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
WO2014142938A1 (en) * 2013-03-15 2014-09-18 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN112336696B (zh) * 2020-12-01 2022-08-05 苏州中化药品工业有限公司 一种长效脉冲制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050244497A1 (en) * 1997-11-05 2005-11-03 Wockhardt Limited Delayed delivery system for acid-sensitive drugs
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
JP4541807B2 (ja) * 2004-09-03 2010-09-08 Ｏｋｉセミコンダクタ株式会社 半導体素子保持装置および半導体素子の搬送方法
AR051654A1 (es) * 2004-11-04 2007-01-31 Astrazeneca Ab Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
CN101888828A (zh) * 2007-07-27 2010-11-17 蒂宝制药公司 脉冲胃滞留剂型
US20090214599A1 (en) * 2008-02-21 2009-08-27 Agi Therapeutics Plc Proton pump inhibitor formulations, and methods of preparing and using such formulations

Also Published As

Publication number Publication date
NZ613090A (en) 2015-11-27
WO2012092486A2 (en) 2012-07-05
EP2661260A2 (en) 2013-11-13
AU2011352037A1 (en) 2013-08-01
CN103402501A (zh) 2013-11-20
UA112855C2 (uk) 2016-11-10
WO2012092486A3 (en) 2012-11-01
EP2661260A4 (en) 2014-05-14

Similar Documents

Publication Publication Date Title
EA201390979A1 (ru) Композиции бензимидазолов с модифицированным высвобождением
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
EA201400972A1 (ru) Лекарственные формы немедленного высвобождения с защитой от несанкционированного применения
EA201201050A1 (ru) Пиразолы в качестве антагонистов crth2
WO2011099832A3 (en) Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same
EA201290506A1 (ru) Частицы для доставки множества агентов
MX348491B (es) Tableta a prueba de manipulacion que proporciona liberacion inmediata de fármaco.
EA201270467A1 (ru) Полициклические соединения в качестве антагонистов рецепторов лизофосфатидной кислоты
UY32036A (es) Derivados de ciclohexil-amida, composiciones farmacéuticas que los contienen, su preparación y aplicaciones
EA033370B1 (ru) Составы рифаксимина и их применение
TR200806298A2 (tr) Farmasötik formülasyon
CL2013000677A1 (es) Composicion farmaceutica en forma de tabletas que comprenden microgranulos gastrointestinales que contienen 100 a 800 mg de rifaximina, hasta 30% p/p de excipientes extragranulares y un recubrimiento formador de pelicula; y uso para tratar una enfermedad infecciosa y/o inflamatoria del intestino, tal como la enfermedad de crohn.
MX2013002422A (es) Sales de lorcaserina con acidos opticamente activos.
RS53467B (en) USE OF AMISULPRID FOR TREATMENT OF Nausea and Vomiting Caused by Chemotherapy
MX2013006418A (es) Derivados de oxazolil-metileter como agonistas del receptor de alx.
GT201500035A (es) Composición farmacéutica oral en forma de microesferas y proceso de elaboración
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
PE20142325A1 (es) Composiciones derivadas de la quitosana
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
MX359713B (es) Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.
EA201001354A1 (ru) Толтразурил с улучшенными свойствами растворения
MX2013013691A (es) Composicion de liberacion sostenida que contiene peptidos como ingredientes activos.
RS52461B (en) FLUPENTIKSOL COMPOSITIONS
EA201071309A1 (ru) Твердая фармацевтическая композиция
TR201109686T2 (tr) Olmesartan'ın Farmasötik Bileşimleri.